Clinical Trials Logo

Clinical Trial Summary

The symptoms of intralabyrinthine schwannomas (vertigo, deafness, instability, tinnitus) cut across the symptoms found in pressure pathologies involving the inner ear, particularly the endolymphatic hydrops.

Some publications have described dilatation of the membranous labyrinth (hydrops) in the presence of intralabyrinthine tumors.

It would be interesting to measure the size of the saccule (structure of the membranous labyrinth) in the presence of an intralabyrinthine schwannoma, to evaluate if some of the symptoms presented by the patients could be explained by the concomitant presence of an endolymphatic hydrops (accessible to drug therapy - Betahistine).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03581396
Study type Observational
Source University Hospital, Strasbourg, France
Contact Aïna VENKATASAMY,, MD
Phone 33 3 88 12 78 65
Email aina.venkatasamy@chru-strasbourg.fr
Status Recruiting
Phase
Start date June 22, 2018
Completion date June 2019